Sunesis Pharmaceuticals, Inc. (SNSS) CEO Dayton Misfeldt on Q2 2020 Results - Earnings Call Transcript
Sunesis Pharmaceuticals, Inc. (SNSS) CEO Dayton Misfeldt on Q2 2020 Results - Earnings Call Transcript
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
-
Elite Pharmaceuticals, Inc. (ELTP) CEO Nasrat Hakim on Q1 2021 Results - Earnings Call Transcript
SeekingAlpha
-
Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q2 2020 Results - Earnings Call Transcript
SeekingAlpha
-
TFF Pharmaceuticals, Inc. (TFFP) CEO Glenn Mattes on Q2 2020 Results - Earnings Call Transcript
SeekingAlpha
-
Salarius Pharmaceuticals, Inc. (SLRX) CEO David Arthur on Q2 2020 Results - Earnings Call Transcript
SeekingAlpha
Advertisement
More coverage
-
Cumberland Pharmaceuticals, Inc. (CPIX) CEO A. J. Kazimi on Q2 2020 Results - Earnings Call Transcript
SeekingAlpha
-
Catalyst Pharmaceuticals, Inc. (CPRX) CEO Patrick McEnany on Q2 2020 Results - Earnings Call Transcript
SeekingAlpha
-
Spectrum Pharmaceuticals, Inc. (SPPI) CEO Joe Turgeon on Q2 2020 Results - Earnings Call Transcript
SeekingAlpha
-
Inovio Pharmaceuticals, Inc. (INO) CEO J. Joseph Kim on Q2 2020 Results - Earnings Call Transcript
SeekingAlpha